Demographic and clinical information*
| Characteristic | Gluten-containing diet (n = 9) | Gluten-free diet (n = 7) |
|---|---|---|
| Mean age, yr | 42.0 ± 14.6 | 32.5 ± 9.7 |
| M/F, no. (%) | 5/4 (56/44) | 4/3 (57/43) |
| Age of onset, yr | 16.9 ± 3.4 | 18.2 ± 2.4 |
| Level of education, yr | 11.8 ± 1.3 | 12.4 ± 2.1 |
| Smoker Y/N, no. (%) | 5/4 (56/44) | 6/1 (86/14) |
| Body mass index, kg/m2 | 28.5 ± 4.7 | 31.4 ± 8.9 |
| Baseline AGA IgG, U | 55.8 ± 28.6 | 43.8 ± 12.2 |
| Baseline AGA IgA, U | 23.6 ± 21.1 | 32.9 ± 28.3 |
| Medications, no. (%)† | ||
| FGA | < 5 | < 5 |
| SGA | < 5 | < 5 |
| Clozapine | < 5 | < 5 |
| FGA + SGA | < 5 | < 5 |
| Antidepressant | 6 (67) | < 5 |
| Anticholinergic | 7 (78) | 6 (86) |
| Comorbid disorders, no. (%)† | ||
| Gastrointestinal disorder | < 5 | < 5 |
| Dermatologic disorder‡ | < 5 | < 5 |
FGA = first-generation antipsychotic; IgA = immunoglobulin A; IgG = immunoglobulin G; SGA = second-generation antipsychotic.
↵* Data with counts fewer than 5 have been suppressed owing to data privacy guidelines.
↵† Distribution of medications and comorbid disorders did not differ between groups.
↵‡ Dermatologic disorders included eczema, urticaria and rash.